Oral or maxillofacial infections

1 paper1 finding

Humans1

Associations

1

Tirzepatide

downin humans1HR 0.7

1 study

Tirzepatide lowers the risk of oral or maxillofacial infections in humans (HR 0.70, 95% CI 0.62-0.79).
Humansin patients with type 2 diabetes mellitus compared with GLP-1RAs1-year
Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study
Diabetes research and clinical practice20 Sep 2026

More on Tirzepatide

Latest

1 in 12 months

Diabetes Research and Clinical Practice20 Sep

Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study

Cohort study of 97,993 peopleGLP-1 receptor agonists